CurveBeam AI (ASX: CVB) chief executive officer Greg Brown joins Small Caps to discuss the company’s ASX listing and impressive $25 million initial public offering.

A specialist in computerised tomography (CT) and artificial intelligence (AI) imaging, the company’s state-of-the-art technology is looming as a game changer in global orthopaedics and bone health treatment and care.

CurveBeam’s flagship HiRise scanner technology provides the capability to carry out traditional CT scans (where a patient lies down) as well as weight-bearing ones (where a patient stands in a normal pose).

Importantly, HiRise has already been granted regulatory clearance from the US Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA).

It has been estimated that the CT market is currently valued at approximately $10 billion, while the bone health addressable market sits at around $4 billion today.

Article:
https://smallcaps.com.au/curvebeam-ai-launches-ipo-global-medical-imaging-opportunities/

For more information on CurveBeam AI:
https://smallcaps.com.au/stocks/asx-cvb/

See omnystudio.com/listener for privacy information.